Bruxism refers to the condition of involuntarily clenching or grinding of teeth. This is mainly done during sleep, but can also occur during periods of wakefulness and stress. Some common symptoms associated with bruxism include excessive tooth wear, jaw pain or tenderness, headaches and earaches. Traditional treatment for bruxism has involved the use of mouth guards or splints to prevent teeth grinding. More recently, several pharmacological therapies targeting triggers like stress and anxiety have also emerged. However, mouth guards continue to be the first line treatment recommended for management of bruxism.
The global Bruxism Treatment Market is estimated to be valued at US$ 1403.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Key Trends:
One of the major trends witnessed in the bruxism treatment market is the increasing demand for customized and advanced bruxism appliances. Conventional mouth guards do not provide targeted relief from teeth clenching and grinding. Hence, manufacturers are focusing on developing more advanced and comfortable bruxism appliances tailored as per the needs of individual patients. For instance, in 2021, Klarity introduced its digitally engineered, customized anti-clenching and anti-grinding clear night guards. Similarly, Shock Doctor introduced its I/O Mouthguard for bruxism treatment in 2020, which comes with an ergonomic design and non-slip grip for high protection and comfort. Such innovations are expected to drive the growth of the global bruxism treatment market during the forecast period.
Porter’s Analysis
Threat of new entrants: Low as it requires substantial capital investment and R&D efforts to develop new drugs.
Bargaining power of buyers: High as there are many companies offering bruxism treatment products.
Bargaining power of suppliers: Moderate as raw materials used in treatment are commodity products.
Threat of new substitutes: Low as there are limited treatment options available currently.
Competitive rivalry: High as the market is dominated by few major players.
Key Takeaways
The global Bruxism Treatment Market Growth is expected to witness high growth. The global Bruxism Treatment Market is estimated to be valued at US$ 1403.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
North America region currently dominates the bruxism treatment market and is expected to continue its dominance over the forecast period. Rising prevalence of bruxism disorder along with increasing awareness are driving the market growth.
Key players related content comprises Key players operating in the Bruxism Treatment market are Siemens. Bruxism is a condition characterized by the habit of teeth clenching or grinding during sleep or during periods of wakefulness. Around 10 to 30 percent of adults have bruxism and it is more common in women than in men. Treatment consists of mouth guards, relaxation techniques, biofeedback, and medications if necessary.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.